Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (Nature Biomedical Engineering, (2021), 5, 9, (983-997), 10.1038/s41551-021-00791-0)

Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan Khan, Sean Bickerton, Michael D. McHugh, Hyun Bong Park, Alyssa L. Siefert, Gerald Rea, José M. Carballido, David A. Horwitz, Jason Criscione, Karlo Perica, Robert Samstein, Ragy Ragheb, Dongin Kim, Tarek M. Fahmy

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (Nature Biomedical Engineering, (2021), 5, 9, (983-997), 10.1038/s41551-021-00791-0)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Engineering & Materials Science

Chemical Compounds